Company Info
Phone(617) 401-9000
Year Established
2013
Ticker
EDIT
Exchange
NASDAQ
Contacts
Gilmore OﾒNeillPresident & CEO
Charlene Stern, Ph.D., J.D.
General Counsel
Erick J. Lucera
CFO
Bruce E. Eaton, Ph.D.
CBO & CTO
Linda C. Burkly, Ph.D.
CSO
Emma Reeve
Chair
Baisong Mei, M.D., Ph.D.
CMO
Caren Deardorf
CCO
Company Description
Editas Medicine is a leading genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world.
